Determination of caffeine and sympathomimetic alkaloids in weight loss supplements by high-performance liquid chromatography

Journal of Chromatographic Science

Volumn 46, Issue 1, 2008, Pages 61-67

  Evans, Ronald L ^a   Siitonen, Paul H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRUS AURANTIUM; EPHEDRA;

EID: 38149010457     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.1.61     Document Type: Article

References (38)

1. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Department of Health and Human Services, Food and Drug Administration. 1-363 (2004).
2. S. Bent, T.N. Tiedt, M.C. Odden, and M.G. Shlipak. The relative safety of ephedra compared with other herbal products. Ann. Intern. Med. 138: 468-71 (2003).
3. S. Bent, A. Padula and J. Neuhaus. Safety and efficacy of citrus aurantium for weight loss. Am. J. Cardiol. 94: 1359-61 (2004).
4. Nutrition & Fitness Newsbriefs. Health News. 10(12): 9 (Dec. 2004).
5. D.L. Nykamp, M.N. Fackih, and A.L. Compton. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann. Pharmacother. 38: 812-16 (2004).
6. J.A. Hurlbut, J.R. Carr, E.R. Singleton, K.C. Faul, M.R. Madson, J.M. Storey, and T.L. Thomas. Solid-phase extraction cleanup and liquid chromatography with ultraviolet detection of ephedrine alkaloids in herbal products. J. AOAC Int. 81(6): 1121-27 (1998).
7. A. Fugh-Berman and A. Myers. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: Current status of clinical and basic research. Exp. Biol. Med. 229: 698-704 (2004).
8. J.E. Gearien. Adrenergic Drugs. In Principles of Medicinal Chemistry, W.O. Foye, Ed.; Lea & Febiger, Philadelphia, PA, 1975, pp. 349-64.
9. R. Jordan, J.M. Midgley, C.M. Thonoor, and C.M. Williams. ?-Adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. J. Pharm. Pharmacol. 39: 752-54 (1987).
10. 3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 359(4): 310-21 (1999).
11. B.B. Hoffman and R.L. Lefkowitz. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In The Pharmacological Basis of Therapeutics, 9th ed. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, Ed.; McGraw-Hill Companies, Inc., New York, NY, 1996, pp. 199-248.
12. F.H.S. Kuniyoshi, I.C. Trombetta, L.T. Batalha, M.U.P.B. Rondon, M.C. Laterza, M.M.G. Gowdak, A.C.P. Barretto, A. Halpern, S.M.F. Villares, E.G. Lima, and C.E. Negrao. Abnormal neurovascular control during sympathoexcitation in obesity. Obesity Res. 11(11): 1411-19 (2003).
13. F. Contaldo, F. Pasanisi, C. Finelli, and G. deSimone. Obesity, heart failure and sudden death. Nutr. Metab. Cardiovasc. Dis. 12: 190-97 (2002).
14. A. Nyska, E. Murphy, J.F. Foley, B.J. Collins, J. Petranka, R. Howden, P. Hanlon, and J.K. Dunnick. Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Toxicol. Sci. 83: 388-96 (2005).
15. T.R. Hartley, W.R. Lovallo, and T.L. Whitsett. Cardiovascular effects of caffeine in men and women. Am. J. Cardiol. 93: 1022-1026 (2004).
16. J.D. Lane, C.F. Pieper, B.G. Phillips-Bute, J.E. Bryant, and C.M. Kuhn. Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosom. Med. 64: 595-603 (2002).
17. P.J. van der Merwe, L.W. Brown, and S.E. Hendrikz. Simultaneous quantification of ephedrines in urine by high-performance liquid chromatography. J. Chromatogr., B 661: 357-61 (1994).
18. N. Okamura, H. Miki, T. Harada, S. Yamashita, Y. Masaoka, Y. Nakamoto, M. Tsuguma, H. Yoshitomi, and A. Yagi. Simultaneous determination of ephedrine, pseudoephedrine, norephedrine and methylephedrine in Kampo medicines by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 20: 363-72 (1999).
19. J. Cui, T. Zhou, J. Zhang, and Z. Lou. Analysis of alkaloids in Chinese ephedra species by gas chromatographic methods. Phytochem. Anal. 2: 116-19 (1991).
20. M.L. Gay, K.D. White, W.R. Obermeyer, J.M. Betz, and S.M. Musser. Determination of ephedrine-type alkaloids in dietary supplements by LC/MS using a stable-isotope labeled internal standard. J. AOAC Int. 84(3): 761-69 (2001).
21. J.M. Betz, M.L. Gay, M.M. Mossoba, S. Adams, and B.S. Portz. Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Ma Huang. J. AOAC Int. 80(2): 303-15 (1997).
22. B.J. Gurley, P. Wang, and S.F. Gardner. Ephedrine-type alkaloid content of nutritional supplements containing ephedra sinica (Mahuang) as determined by high performance liquid chromatography. J. Pharm. Sci. 87(12): 1547-53 (1998).
23. P. Jacob III, C.A. Haller, M. Duan, L. Yu, M. Peng, and N.L. Benowitz. Determination of ephedra alkaloids and caffeine concentrations in dietary supplements and biological fluids. J. Anal. Toxicol. 28: 152-59 (2004).
24. C.A. Haller, M. Duan, N.L. Benowitz, and P. Jacob III. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J. Anal. Toxicol. 28: 145-51 (2004).
25. R.A. Niemann and M.L. Gay. Determination of ephedrine alkaloids and synephrine in dietary supplements by column-switching cation exchange high-performance liquid chromatography with scanning-wavelength ultraviolet and fluorescence detection. J. Agric. Food Chem. 51: 5630-38 (2003).
26. F. Pellati, S. Benvenuti, M. Melegari, and F. Firenzuoli. Determination of adrenergic agonists from extracts and herbal products of citrus aurantium L. var. amara by LC. J. Pharm. Biomed. Anal. 29: 1113-19 (2002).
27. S.R. Penzak, M.W. Jann, J.A. Gold, Y.Y. Hon, H.D. Desai, and B.J. Gurley. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J. Clin. Pharmacol. 41: 1059-63 (2001).
28. F. Pellati, S. Benvenuti, and M. Melegari. High-performance liquid chromatography methods for the analysis of adrenergic amines and flavanones in citrus aurantium L. var. amara. Phytochem. Anal. 15: 220-25 (2004).
29. B.T. Schaneberg and I.A. Khan. Quantitative and qualitative HPLC analysis of thermogenic weight loss products. Pharmazie 59: 819-23 (2004).
30. W.F. Huang, K. Wen, and M. Hsiao. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J. Clin. Pharmacol. 37: 344-50 (1997).
31. J. Corley. Best Practices in Establishing Detection and Quantification Limits for Pesticide Residues in Foods. In Handbook of Residue Analytical Methods for Agrochemicals, Volumes 1-2, P.W. Lee, Ed. John Wiley & Sons Inc., New York, NY, 2003, pp. 59-75.
32. B.J. Gurley, S.F. Gardner and M.A. Hubbard. Content versus label claims in ephedra-containing dietary supplements. Am. J. Health Syst. Pharm. 57: 963-69 (2000).
33. B.T. Schaneberg, S. Crockett, E. Bedir and I.A. Khan. The role of chemical fingerprinting: application to Ephedra. Phytochemistry 62: 911-18 (2003).
34. C.A. Haller, K.M. Meier and K.R. Olsen. Seizures reported in association with use of dietary supplements. Clin. Toxicol. 1: 23-30 (2005).
35. G. D'Andrea, S. Terrazzino, D. Fortin, P. Cocco, T. Balbi and A. Leon. Elusive amines and primary headaches: historical background and prospectives. Neurol. Sci. 24: S65-S67 (2003).
36. G. D'Andrea, S. Terrazzino, A. Leon, D. Fortin, F. Perini, F. Granella and G. Bussone. Elevated levels of circulating trace amines in primary headaches. Neurology 62: 1701-1705 (2004).
37. M. Etminan, B. Takkouche, F. Caamano Isorna and A. Samii. Risk of ischaemic stroke in people with migraine: systemic review and meta-analysis of observational studies. BMJ 330(7482): 63 (2005).
38. B.A. Bidlingmeyer. Considerations for proper operation of a liquid chromatograph. In Practical HPLC Methodology and Applications, John Wiley & Sons, Inc., New York, NY, 1992, pp. 207-283.